Artivion | CRY - 운영 비용

주가
38.40
매일 변경
1.66 4.52%
매월
4.72%
매년
70.44%
Q2 예상
36.60




운영 비용 변화 날짜
Abbott USD 9.31B 104M 2026-03
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Inogen USD 49.14M 665K 2024-09
Integra LifeSciences USD 368.92M 668.65M 2025-12
J&J USD 17.44B 1.53B 2026-03
Mesa Laboratories USD 33.98M 2.03M 2024-12
Orthofix International USD 213.79M 12.36M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
ResMed USD 925.21M 51.98M 2025-12
Stryker USD 5.2B 505M 2025-12
Surmodics USD 29.51M 274.86M 2025-06
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Terumo JPY 252.74B 22.88B 2025-12
Trinity Biotech USD 14.82M 7.81M 2025-09